Share-based Payment Arrangement, Expense in USD of NEOGENOMICS INC from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Neogenomics Inc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2011 to Q3 2025.
  • Neogenomics Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $10.3M, a 21.7% increase year-over-year.
  • Neogenomics Inc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $41.6M, a 29.7% increase year-over-year.
  • Neogenomics Inc annual Share-based Payment Arrangement, Expense for 2024 was $33.4M, a 35.6% increase from 2023.
  • Neogenomics Inc annual Share-based Payment Arrangement, Expense for 2023 was $24.6M, a 0.16% decline from 2022.
  • Neogenomics Inc annual Share-based Payment Arrangement, Expense for 2022 was $24.7M, a 9.65% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NEOGENOMICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $41.6M $10.3M +$1.84M +21.7% 01 Jul 2025 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $39.8M $12.2M +$3.37M +38.2% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $36.4M $10.8M +$2.98M +38.3% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $33.4M $8.33M +$1.34M +19.1% 01 Oct 2024 31 Dec 2024 10-K 18 Feb 2025
Q3 2024 $32.1M $8.47M +$1.29M +18% 01 Jul 2024 30 Sep 2024 10-Q 28 Oct 2025
Q2 2024 $30.8M $8.84M +$3.14M +55% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025
Q1 2024 $27.6M $7.77M +$3.02M +63.4% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q4 2023 $24.6M $6.99M +$2.32M +49.6% 01 Oct 2023 31 Dec 2023 10-K 18 Feb 2025
Q3 2023 $22.3M $7.18M +$2.88M +67% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 $19.4M $5.71M +$2.11M +58.5% 01 Apr 2023 30 Jun 2023 10-Q 30 Jul 2024
Q1 2023 $17.3M $4.76M -$7.34M -60.7% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 $24.7M $4.67M -$5.43M -53.7% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025
Q3 2022 $30.1M $4.3M -$900K -17.3% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 $31M $3.6M -$900K -20% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $31.9M $12.1M +$9.4M +348% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $22.5M $10.1M 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 $5.2M +$2.5M +92.6% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 $4.5M +$1.9M +73.1% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $2.7M +$500K +22.7% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q3 2020 $2.7M -$600K -18.2% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $2.6M +$300K +13% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $2.2M +$100K +4.76% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q3 2019 $3.3M +$2.2M +200% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020
Q2 2019 $2.3M 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020
Q1 2019 $2.1M +$500K +31.3% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q3 2018 $1.1M -$1.7M -60.7% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q1 2018 $1.6M 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q3 2017 $2.8M 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q3 2015 $828K +$508K +159% 01 Jul 2015 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 $508K +$351K +224% 01 Apr 2015 30 Jun 2015 10-Q 31 Jul 2015
Q1 2015 $342K +$253K +284% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015
Q3 2014 $320K 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 $157K 01 Apr 2014 30 Jun 2014 10-Q 31 Jul 2015
Q1 2014 $89K 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015

NEOGENOMICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $33.4M +$8.78M +35.6% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025
2023 $24.6M -$39K -0.16% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025
2022 $24.7M +$2.17M +9.65% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025
2021 $22.5M 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2012 $575K +$290K +102% 01 Jan 2012 31 Dec 2012 10-K 21 Feb 2013
2011 $285K 01 Jan 2011 31 Dec 2011 10-K 21 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.